Action BDRL BLONDER TONGUE LABORATORIES, INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Blonder Tongue Laboratories, Inc.

Actions

BDRL

US0936981085

Temps Différé OTC Markets
Autres places de cotation
 16:58:06 13/05/2024 		Varia. 5j. Varia. 1 janv.
0,1141 USD -12,24% Graphique intraday de Blonder Tongue Laboratories, Inc. -12,23% +40,00%
2023 Blonder Tongue annonce l'ajout d'une fonction de basculement IP au système de diffusion vidéo NXG CI
2023 Blonder Tongue Laboratories, Inc. annonce ses résultats pour l'exercice clos le 31 décembre 2022 CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Blonder Tongue Announces IP Failover Feature Added to NXG Video Delivery System
BLONDER TONGUE LABORATORIES INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)
Tranche Update on Blonder Tongue Laboratories, Inc.'s Equity Buyback Plan announced on February 13, 2007.
Tranche Update on Blonder Tongue Laboratories, Inc.'s Equity Buyback Plan announced on July 24, 2002.
Blonder Tongue Laboratories, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
Blonder Tongue Laboratories, Inc. Auditor Raises 'Going Concern' Doubt
BLONDER TONGUE LABORATORIES INC : Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
Blonder Tongue Announces Demise of Eric Skolnik, Senior Vice President
Blonder Tongue Announces Demise of Eric Skolnik, Chief Financial Officer; Appoints Michael Censoplano as Interim CFO
BLONDER TONGUE LABORATORIES INC : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
Blonder Tongue Laboratories, Inc. Announces the Retirement of Stephen K. Necessary from the Board
BLONDER TONGUE LABORATORIES INC : Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
Blonder Tongue Laboratories, Inc. Announces President Changes
Blonder Tongue Laboratories, Inc. Announces Chief Executive Officer Changes
BLONDER TONGUE LABORATORIES INC : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
BLONDER TONGUE LABORATORIES INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
Tranche Update on Blonder Tongue Laboratories, Inc.'s Equity Buyback Plan announced on July 24, 2002.
Tranche Update on Blonder Tongue Laboratories, Inc.'s Equity Buyback Plan announced on February 13, 2007.
Blonder Tongue Laboratories, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
Earnings Flash (BDRL) BLONDER TONGUE LABORATORIES Posts Q3 Revenue $5.3M
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action BDRL
  4. Actualités Blonder Tongue Laboratories, Inc.
  5. Autres langues